GLSI
Price:
$13.09
Market Cap:
$172.06M
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.[Read more]
Industry
Biotechnology
IPO Date
2020-09-25
Stock Exchange
NASDAQ
Ticker
GLSI
According to Greenwich LifeSciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -153.95%. This represents a change of 283.27% compared to the average of -40.17% of the last 4 quarters.
The mean historical ROE of Greenwich LifeSciences, Inc. over the last ten years is 10.69%. The current -153.95% ROE has changed -1540.34% with respect to the historical average. Over the past ten years (40 quarters), GLSI's ROE was at its highest in in the December 2019 quarter at 24.92%. The ROE was at its lowest in in the March 2024 quarter at -48.30%.
Average
10.69%
Median
-6.74%
Minimum
-132.71%
Maximum
253.65%
Discovering the peaks and valleys of Greenwich LifeSciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.42%
Maximum Annual ROE = 253.65%
Minimum Annual Increase = -102.66%
Minimum Annual ROE = -132.71%
Year | ROE | Change |
---|---|---|
2023 | -132.71% | 130.43% |
2022 | -57.59% | 240.13% |
2021 | -16.93% | 151.25% |
2020 | -6.74% | -102.66% |
2019 | 253.65% | 1.42% |
2018 | 16.70% | -9.48% |
The current ROE of Greenwich LifeSciences, Inc. (GLSI) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-69.08%
5-year avg
7.94%
10-year avg
10.69%
Greenwich LifeSciences, Inc.’s ROE is less than Reviva Pharmaceuticals Holdings, Inc. (664.92%), greater than Eyenovia, Inc. (-615.55%), greater than Immutep Limited (-42.11%), greater than Anavex Life Sciences Corp. (-30.62%), greater than Virpax Pharmaceuticals, Inc. (-1554.74%), greater than Acurx Pharmaceuticals, Inc. (-371.20%), greater than MediciNova, Inc. (-13.37%), greater than NextCure, Inc. (-57.63%), greater than Entera Bio Ltd. (-100.37%), less than X4 Pharmaceuticals, Inc. (32.93%), greater than Terns Pharmaceuticals, Inc. (-39.58%), greater than Day One Biopharmaceuticals, Inc. (-22.40%), greater than PDS Biotechnology Corporation (-137.06%), greater than Inozyme Pharma, Inc. (-68.93%), less than Amylyx Pharmaceuticals, Inc. (0%), greater than Acumen Pharmaceuticals, Inc. (-46.15%), greater than null (-24.63%),
Company | ROE | Market cap |
---|---|---|
664.92% | $33.39M | |
-615.55% | $44.32M | |
-42.11% | $266.19M | |
-30.62% | $619.01M | |
-1554.74% | $3.47M | |
-371.20% | $30.05M | |
-13.37% | $82.40M | |
-57.63% | $36.65M | |
-100.37% | $64.66M | |
32.93% | $89.59M | |
-39.58% | $599.50M | |
-22.40% | $1.49B | |
-137.06% | $118.93M | |
-68.93% | $277.29M | |
0% | $388.07M | |
-46.15% | $177.24M | |
-24.63% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Greenwich LifeSciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Greenwich LifeSciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Greenwich LifeSciences, Inc.'s ROE?
How is the ROE calculated for Greenwich LifeSciences, Inc. (GLSI)?
What is the highest ROE for Greenwich LifeSciences, Inc. (GLSI)?
What is the 3-year average ROE for Greenwich LifeSciences, Inc. (GLSI)?
What is the 5-year average ROE for Greenwich LifeSciences, Inc. (GLSI)?
How does the current ROE for Greenwich LifeSciences, Inc. (GLSI) compare to its historical average?